JPRN-UMIN000023989已完成2 期
Efficacy and safety of hydroxychloroquine for Japanese patients with rheumatoid arthritis - Efficacy and safety of hydroxychloroquine for Japanese patients with rheumatoid arthritis
Division of Rheumatology, Keio University School of Medicine0 个研究点目标入组 60 人开始时间: 2017年1月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
The addition of HCQ to csDMARDs was effective, with no new safety signal in patients with RA.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Pregnancy or hope to bear a child 2) Contraindication to HCQ, e.g. history of retinopathy and hypersensitivity to 4-aminoquinoline 3) Uncontrollable diabetes mellitus 4) Porphyria 5) Psoriasis 6) G6PD deficiency 7) Ineligible for the study judged by physicians
研究者
相似试验
已完成
2 期
Hydroxychloroquine for Japanese patients with rheumatoid arthritisD001172Rheumatoid arthritisJPRN-jRCTs031180050Kaneko Yuko60
撤回
3 期
Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health ProfessionalsCOVID19Sars-CoV2HydroxychloroquineProphylaxisHealthcare WorkerNCT04349228Abderrahmane Mami Hospital
已完成
2 期
Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic CancerPancreatic CancerNCT01273805Dana-Farber Cancer Institute20
已完成
不适用
Efficacy and safety of hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome patients with annular erythema on the face and/or trunkSystemic/cutaneous lupus erythematosus Sjogren's syndromeJPRN-UMIN000004477Kanazawa University Graduate School of Medical Science10
已完成
2 期
A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)GlioblastomaNCT01602588University College, London54